Adiposs was honored to participate in the Top100 Swiss Investor Summit 2026 in Zurich, where Reinhard Stary, our Chairman, presented the company and ImageBAT® to an audience of Swiss and international investors.
The invitation-only Investor Summit brings together selected Swiss startups with investors from across venture capital, corporate investment, family offices, and the business angel community, offering a platform to showcase emerging technologies and connect with partners for the next stage of growth.
For Adiposs, the event was an opportunity to present ImageBAT® (our first-in-class oral contrast agent for brown fat imaging) to the investment community, and to engage with investors interested in disruptive biotech innovation.
We thank the Top100 team for the invitation and for convening such an engaged community of entrepreneurs and investors.
